1. Home
  2. MURA vs HUBC Comparison

MURA vs HUBC Comparison

Compare MURA & HUBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MURA
  • HUBC
  • Stock Information
  • Founded
  • MURA 2013
  • HUBC 2017
  • Country
  • MURA Ireland
  • HUBC Israel
  • Employees
  • MURA N/A
  • HUBC N/A
  • Industry
  • MURA
  • HUBC
  • Sector
  • MURA
  • HUBC
  • Exchange
  • MURA Nasdaq
  • HUBC Nasdaq
  • Market Cap
  • MURA 36.0M
  • HUBC 32.0M
  • IPO Year
  • MURA N/A
  • HUBC N/A
  • Fundamental
  • Price
  • MURA $2.10
  • HUBC $0.99
  • Analyst Decision
  • MURA Buy
  • HUBC
  • Analyst Count
  • MURA 2
  • HUBC 0
  • Target Price
  • MURA $6.00
  • HUBC N/A
  • AVG Volume (30 Days)
  • MURA 112.3K
  • HUBC 405.7K
  • Earning Date
  • MURA 11-06-2025
  • HUBC 05-01-2026
  • Dividend Yield
  • MURA N/A
  • HUBC N/A
  • EPS Growth
  • MURA N/A
  • HUBC N/A
  • EPS
  • MURA N/A
  • HUBC N/A
  • Revenue
  • MURA N/A
  • HUBC $29,562,000.00
  • Revenue This Year
  • MURA N/A
  • HUBC N/A
  • Revenue Next Year
  • MURA N/A
  • HUBC N/A
  • P/E Ratio
  • MURA N/A
  • HUBC N/A
  • Revenue Growth
  • MURA N/A
  • HUBC N/A
  • 52 Week Low
  • MURA $0.95
  • HUBC $0.98
  • 52 Week High
  • MURA $4.74
  • HUBC $14.00
  • Technical
  • Relative Strength Index (RSI)
  • MURA 51.21
  • HUBC 27.11
  • Support Level
  • MURA $2.06
  • HUBC $1.03
  • Resistance Level
  • MURA $2.10
  • HUBC $1.28
  • Average True Range (ATR)
  • MURA 0.02
  • HUBC 0.13
  • MACD
  • MURA -0.00
  • HUBC -0.02
  • Stochastic Oscillator
  • MURA 50.00
  • HUBC 1.05

About MURA Mural Oncology plc

Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.

About HUBC Hub Cyber Security Ltd.

Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.

Share on Social Networks: